Subscribe free

Cytoreductive Surgery & Peritoneum ·

Surgical complications from CRS and HIPEC in cancer patients

A narrative review assessed complications linked to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients battling peritoneal metastasis. It cataloged categories of complications, including surgical, chemotherapy-related, and systemic issues, emphasizing the high morbidity associated with these interventions. The findings advocate for stringent patient selection, precise surgical techniques, and robust intraoperative care. Interdisciplinary collaboration is highlighted as essential to enhance safety and tailor treatment approaches, guiding future clinical practices in managing colorectal cancer metastases effectively.

Review by Karimi M, Shirsalimi N and Sedighi E in Front Surg

© 2024 Karimi, Shirsalimi and Sedighi.

read the whole article in Front Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Cytoreductive Surgery & Peritoneum.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Cytoreductive Surgery & Peritoneum

The latest stitches

Ann Surg Oncol28 Aug 2026

Prophylactic HIPEC Improves Survival in Advanced Colorectal Cancer

Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) significantly enhances peritoneal metastasis-free survival and disease-free survival in patients with locally advanced colorectal cancer, though overall survival rates and complication rates remain unchanged.

All papers in Cytoreductive Surgery & Peritoneum →